Reuters -- AngioDynamics Inc’s (ANGO.O) quarterly profit scraped past market estimates, helped mainly by higher sales at its oncology/surgery and peripheral vascular businesses, and backed its full-year outlook.
Reuters -- AngioDynamics Inc’s (ANGO.O) quarterly profit scraped past market estimates, helped mainly by higher sales at its oncology/surgery and peripheral vascular businesses, and backed its full-year outlook.
